NCT07865936Recruiting
Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients
Association of Cardiovascular Disease Risk Assessment With Coronary Artery Calcium Score in Thai Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in Thailand and is strongly linked to metabolic risk factors such as obesity, diabetes, hypertension, and dyslipidemia. Cardiovascular disease is the leading cause of death among patients with MASLD. Coronary artery calcium (CAC) scoring is a widely used marker of subclinical coronary atherosclerosis. This study aims to evaluate the association between cardiovascular risk assessment tools and CAC scores in Thai patients with MASLD to improve cardiovascular risk stratification in this population.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 251 (estimated)
- First submitted
- 3 Oct 2026
- Start date
- 24 Jun 2026
- Primary completion date
- 23 May 2027
- Lead sponsor
- Watcharasak Chotiyaputta
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07865936
What you commit to
- Study type: Observational
- Planned participants: 251
- From 24 Jun 2026 to the primary completion date, 23 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of myocardial infarction, PCI, or CABG
- History of stroke or peripheral arterial disease
- History of heart failure, RV dysfunction, or pulmonary hypertension
- Chronic hepatitis B or C
- Autoimmune hepatitis, Wilson's disease, hemochromatosis
- Advanced cancer
Other
- Alcohol intake \>30 g/day (men) or \>20 g/day (women)
- CKD stage 4-5 or ESRD
- Pregnancy
Who the study is looking for
- Asymptomatic
- Diagnosed MASLD by: Ultrasound showing fatty liver, or FibroScan CAP ≥ 248 dB/m
- Available liver fibrosis assessment (FIB-4, APRI)
- Complete clinical and laboratory data required for cardiovascular risk assessment
Age in the registry: 35 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine Siriraj Hospital, Mahidol University Coordinator of this site? Confirm its status | Bangkok | Thailand | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.